

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.03511756 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 8.65356170 |
| 3 | myofibril assembly (GO:0030239) | 7.74678581 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.62920849 |
| 5 | sarcomere organization (GO:0045214) | 7.57260043 |
| 6 | striated muscle contraction (GO:0006941) | 7.55896798 |
| 7 | actin filament-based movement (GO:0030048) | 7.42266364 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 7.16957539 |
| 9 | creatine metabolic process (GO:0006600) | 7.07963543 |
| 10 | response to muscle activity (GO:0014850) | 6.60870224 |
| 11 | cardiac myofibril assembly (GO:0055003) | 6.46859861 |
| 12 | cardiac muscle contraction (GO:0060048) | 6.28284174 |
| 13 | response to inactivity (GO:0014854) | 6.04337131 |
| 14 | regulation of actin filament-based movement (GO:1903115) | 5.91724237 |
| 15 | regulation of cell communication by electrical coupling (GO:0010649) | 5.85788555 |
| 16 | skeletal muscle fiber development (GO:0048741) | 5.68489161 |
| 17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.67847224 |
| 18 | muscle contraction (GO:0006936) | 5.64586660 |
| 19 | actomyosin structure organization (GO:0031032) | 5.56296033 |
| 20 | skeletal muscle adaptation (GO:0043501) | 5.47704739 |
| 21 | NADH metabolic process (GO:0006734) | 5.35473532 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.35168532 |
| 23 | cardiac muscle hypertrophy (GO:0003300) | 5.29863779 |
| 24 | myotube cell development (GO:0014904) | 5.19883579 |
| 25 | glycogen catabolic process (GO:0005980) | 5.19605124 |
| 26 | muscle system process (GO:0003012) | 5.05590287 |
| 27 | striated muscle hypertrophy (GO:0014897) | 5.04338522 |
| 28 | plasma membrane repair (GO:0001778) | 4.97528192 |
| 29 | glucan catabolic process (GO:0009251) | 4.88325557 |
| 30 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.87181728 |
| 31 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.78666234 |
| 32 | glucan biosynthetic process (GO:0009250) | 4.71126992 |
| 33 | glycogen biosynthetic process (GO:0005978) | 4.71126992 |
| 34 | muscle fiber development (GO:0048747) | 4.67799480 |
| 35 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.62824174 |
| 36 | cellular polysaccharide catabolic process (GO:0044247) | 4.58812952 |
| 37 | muscle hypertrophy (GO:0014896) | 4.49611857 |
| 38 | muscle tissue morphogenesis (GO:0060415) | 4.49338073 |
| 39 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.46912227 |
| 40 | central nervous system myelination (GO:0022010) | 4.44728796 |
| 41 | axon ensheathment in central nervous system (GO:0032291) | 4.44728796 |
| 42 | regulation of striated muscle contraction (GO:0006942) | 4.40923588 |
| 43 | striated muscle adaptation (GO:0014888) | 4.40557289 |
| 44 | skeletal muscle tissue development (GO:0007519) | 4.35891372 |
| 45 | adult heart development (GO:0007512) | 4.27520098 |
| 46 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.26800162 |
| 47 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.24967499 |
| 48 | carnitine shuttle (GO:0006853) | 4.24761370 |
| 49 | 2-oxoglutarate metabolic process (GO:0006103) | 4.20189338 |
| 50 | tricarboxylic acid cycle (GO:0006099) | 4.16816355 |
| 51 | heart contraction (GO:0060047) | 4.15700810 |
| 52 | heart process (GO:0003015) | 4.15700810 |
| 53 | cardiac muscle cell development (GO:0055013) | 4.14163099 |
| 54 | polysaccharide catabolic process (GO:0000272) | 4.13236904 |
| 55 | skeletal muscle tissue regeneration (GO:0043403) | 4.02899494 |
| 56 | regulation of the force of heart contraction (GO:0002026) | 4.01903540 |
| 57 | muscle cell cellular homeostasis (GO:0046716) | 4.00162743 |
| 58 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.96423423 |
| 59 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.96423423 |
| 60 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.92102432 |
| 61 | striated muscle cell development (GO:0055002) | 3.86546207 |
| 62 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.84497798 |
| 63 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.84497798 |
| 64 | cardiac cell development (GO:0055006) | 3.83602783 |
| 65 | glycogen metabolic process (GO:0005977) | 3.81386127 |
| 66 | limb bud formation (GO:0060174) | 3.74987026 |
| 67 | cellular glucan metabolic process (GO:0006073) | 3.73784581 |
| 68 | glucan metabolic process (GO:0044042) | 3.73784581 |
| 69 | superoxide anion generation (GO:0042554) | 3.70463148 |
| 70 | gluconeogenesis (GO:0006094) | 3.70076930 |
| 71 | fructose metabolic process (GO:0006000) | 3.69363635 |
| 72 | cardiac muscle adaptation (GO:0014887) | 3.64579963 |
| 73 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.64579963 |
| 74 | muscle hypertrophy in response to stress (GO:0003299) | 3.64579963 |
| 75 | muscle organ morphogenesis (GO:0048644) | 3.64534270 |
| 76 | regulation of timing of cell differentiation (GO:0048505) | 3.62799660 |
| 77 | fatty acid transmembrane transport (GO:1902001) | 3.61936798 |
| 78 | striated muscle atrophy (GO:0014891) | 3.60069505 |
| 79 | centriole assembly (GO:0098534) | 3.58666825 |
| 80 | response to activity (GO:0014823) | 3.56956133 |
| 81 | muscle structure development (GO:0061061) | 3.56445109 |
| 82 | muscle organ development (GO:0007517) | 3.54742173 |
| 83 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.54507516 |
| 84 | regulation of sequestering of triglyceride (GO:0010889) | 3.54377047 |
| 85 | muscle adaptation (GO:0043500) | 3.54335157 |
| 86 | relaxation of muscle (GO:0090075) | 3.52799807 |
| 87 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.51689404 |
| 88 | muscle cell fate commitment (GO:0042693) | 3.51295194 |
| 89 | positive regulation of cation channel activity (GO:2001259) | 3.49047449 |
| 90 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.48771927 |
| 91 | positive regulation of myotube differentiation (GO:0010831) | 3.48399459 |
| 92 | presynaptic membrane assembly (GO:0097105) | 3.47788156 |
| 93 | regulation of membrane repolarization (GO:0060306) | 3.46627565 |
| 94 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.38620640 |
| 95 | GPI anchor biosynthetic process (GO:0006506) | 3.37399828 |
| 96 | adenosine metabolic process (GO:0046085) | 3.36169492 |
| 97 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33779753 |
| 98 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.32520254 |
| 99 | regulation of muscle system process (GO:0090257) | 3.32127566 |
| 100 | regulation of ATP catabolic process (GO:1903289) | 3.31780947 |
| 101 | regulation of ATPase activity (GO:0043462) | 3.31780947 |
| 102 | muscle cell development (GO:0055001) | 3.30040763 |
| 103 | hexose biosynthetic process (GO:0019319) | 3.29583293 |
| 104 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.28669285 |
| 105 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.28282432 |
| 106 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.28282432 |
| 107 | regulation of development, heterochronic (GO:0040034) | 3.25820059 |
| 108 | ubiquinone biosynthetic process (GO:0006744) | 3.24562533 |
| 109 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.23980703 |
| 110 | regulation of muscle contraction (GO:0006937) | 3.23854027 |
| 111 | carnitine transmembrane transport (GO:1902603) | 3.22943273 |
| 112 | muscle atrophy (GO:0014889) | 3.22816262 |
| 113 | histone H2B ubiquitination (GO:0033523) | 3.22659516 |
| 114 | cell proliferation in forebrain (GO:0021846) | 3.18698543 |
| 115 | presynaptic membrane organization (GO:0097090) | 3.18010057 |
| 116 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.17710055 |
| 117 | positive regulation of protein homodimerization activity (GO:0090073) | 3.16916348 |
| 118 | keratinocyte development (GO:0003334) | 3.13859571 |
| 119 | negative regulation of myoblast differentiation (GO:0045662) | 3.03989794 |
| 120 | GPI anchor metabolic process (GO:0006505) | 3.01822705 |
| 121 | righting reflex (GO:0060013) | 3.00848487 |
| 122 | postsynaptic membrane organization (GO:0001941) | 2.96310984 |
| 123 | negative regulation of protein localization to cell surface (GO:2000009) | 2.94898444 |
| 124 | microtubule depolymerization (GO:0007019) | 2.87379614 |
| 125 | DNA ligation (GO:0006266) | 2.84157128 |
| 126 | positive regulation of action potential (GO:0045760) | 2.79087724 |
| 127 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.77747188 |
| 128 | negative regulation of muscle hypertrophy (GO:0014741) | 2.73895499 |
| 129 | developmental pigmentation (GO:0048066) | 2.72314444 |
| 130 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.71736145 |
| 131 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.69371415 |
| 132 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.68715914 |
| 133 | neuron cell-cell adhesion (GO:0007158) | 2.66723913 |
| 134 | regulation of somitogenesis (GO:0014807) | 2.66462339 |
| 135 | axonemal dynein complex assembly (GO:0070286) | 2.66448246 |
| 136 | centriole replication (GO:0007099) | 2.65734980 |
| 137 | regulation of feeding behavior (GO:0060259) | 2.65497152 |
| 138 | G-protein coupled receptor internalization (GO:0002031) | 2.65268890 |
| 139 | organ growth (GO:0035265) | 2.64825204 |
| 140 | startle response (GO:0001964) | 2.64465891 |
| 141 | DNA integration (GO:0015074) | 2.64356779 |
| 142 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.62637449 |
| 143 | retina layer formation (GO:0010842) | 2.60244658 |
| 144 | amino sugar catabolic process (GO:0046348) | 2.59328258 |
| 145 | polyol transport (GO:0015791) | 2.57581703 |
| 146 | cell differentiation involved in metanephros development (GO:0072202) | 2.57037269 |
| 147 | female gonad development (GO:0008585) | 2.56858891 |
| 148 | positive regulation of microtubule polymerization (GO:0031116) | 2.56759688 |
| 149 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.55765798 |
| 150 | regulation of platelet aggregation (GO:0090330) | 2.53298951 |
| 151 | RNA destabilization (GO:0050779) | 2.50755770 |
| 152 | spinal cord motor neuron differentiation (GO:0021522) | 2.50061615 |
| 153 | auditory receptor cell stereocilium organization (GO:0060088) | 2.49701430 |
| 154 | protein heterotetramerization (GO:0051290) | 2.48895580 |
| 155 | oligosaccharide catabolic process (GO:0009313) | 2.48576234 |
| 156 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.46986318 |
| 157 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.46499007 |
| 158 | lymphoid progenitor cell differentiation (GO:0002320) | 2.45214033 |
| 159 | androgen biosynthetic process (GO:0006702) | 2.44744209 |
| 160 | regulation of activation of Janus kinase activity (GO:0010533) | 2.44239142 |
| 161 | ceramide catabolic process (GO:0046514) | 2.44238453 |
| 162 | otic vesicle formation (GO:0030916) | 2.44150283 |
| 163 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.43849371 |
| 164 | eye photoreceptor cell differentiation (GO:0001754) | 2.43616062 |
| 165 | photoreceptor cell differentiation (GO:0046530) | 2.43616062 |
| 166 | histone H3-K4 trimethylation (GO:0080182) | 2.43177274 |
| 167 | DNA damage response, detection of DNA damage (GO:0042769) | 2.42715359 |
| 168 | inner ear receptor stereocilium organization (GO:0060122) | 2.42668406 |
| 169 | microtubule polymerization or depolymerization (GO:0031109) | 2.41377610 |
| 170 | spinal cord association neuron differentiation (GO:0021527) | 2.41220330 |
| 171 | oligodendrocyte differentiation (GO:0048709) | 2.39516236 |
| 172 | cell differentiation in spinal cord (GO:0021515) | 2.39094568 |
| 173 | skeletal muscle contraction (GO:0003009) | 2.37920665 |
| 174 | import into cell (GO:0098657) | 2.36476405 |
| 175 | cyclic nucleotide catabolic process (GO:0009214) | 2.34560134 |
| 176 | forebrain neuron differentiation (GO:0021879) | 2.33241833 |
| 177 | photoreceptor cell maintenance (GO:0045494) | 2.32973500 |
| 178 | regulation of NIK/NF-kappaB signaling (GO:1901222) | 2.29833781 |
| 179 | positive regulation of NIK/NF-kappaB signaling (GO:1901224) | 2.27436216 |
| 180 | synapsis (GO:0007129) | 2.27091334 |
| 181 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.26500733 |
| 182 | left/right axis specification (GO:0070986) | 2.25506999 |
| 183 | regulation of interleukin-8 secretion (GO:2000482) | 2.25285139 |
| 184 | glycolipid biosynthetic process (GO:0009247) | 2.24656132 |
| 185 | sympathetic nervous system development (GO:0048485) | 2.24462483 |
| 186 | positive regulation of cell fate commitment (GO:0010455) | 2.24319308 |
| 187 | mesonephros development (GO:0001823) | 2.23752289 |
| 188 | glycosphingolipid catabolic process (GO:0046479) | 2.23315914 |
| 189 | cilium movement (GO:0003341) | 2.23275534 |
| 190 | nonmotile primary cilium assembly (GO:0035058) | 2.21627651 |
| 191 | detection of light stimulus involved in visual perception (GO:0050908) | 2.21523717 |
| 192 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.21523717 |
| 193 | cornea development in camera-type eye (GO:0061303) | 2.21026454 |
| 194 | reflex (GO:0060004) | 2.20905696 |
| 195 | muscle filament sliding (GO:0030049) | 12.2030373 |
| 196 | actin-myosin filament sliding (GO:0033275) | 12.2030373 |
| 197 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.0964083 |
| 198 | actin-mediated cell contraction (GO:0070252) | 10.0225387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.39254622 |
| 2 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.69280406 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61120473 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.60677436 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.21621939 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.21621939 |
| 7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.08496893 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.05628842 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.85921524 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.85804375 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.80442409 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.78164947 |
| 13 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.66931831 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.63832157 |
| 15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.62461514 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.61193363 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.57722167 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53230683 |
| 19 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.39630442 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38751109 |
| 21 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.38519193 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.32428216 |
| 23 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.31884597 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25831481 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.20479295 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.19880232 |
| 27 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.18856191 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17186945 |
| 29 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.10085549 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03331085 |
| 31 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.02802039 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.99453196 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95735848 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.92570676 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.89183752 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.86421287 |
| 37 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.85642351 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77783319 |
| 39 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.77462614 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76690542 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.74466699 |
| 42 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.73753872 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72385761 |
| 44 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.71906625 |
| 45 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.71341945 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70424390 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.70402735 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70204720 |
| 49 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.69896013 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.69649250 |
| 51 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.69550514 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69189629 |
| 53 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.66276654 |
| 54 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.65841101 |
| 55 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.65629133 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.65304531 |
| 57 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.64741678 |
| 58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.64741678 |
| 59 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.63298311 |
| 60 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.62903867 |
| 61 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.62561778 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60926690 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57980053 |
| 64 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.56699219 |
| 65 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52311843 |
| 66 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.51971617 |
| 67 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.51662105 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51292711 |
| 69 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.51123904 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48227566 |
| 71 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48155570 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47253539 |
| 73 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.47112154 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46969977 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46636146 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44636260 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.43102716 |
| 78 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.43020121 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42845474 |
| 80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42672526 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42637504 |
| 82 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.42256116 |
| 83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41733198 |
| 84 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.41717396 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40766917 |
| 86 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40627425 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38594915 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.37581311 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37112224 |
| 90 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.35862479 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35352616 |
| 92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.34506586 |
| 93 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.34124299 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34037674 |
| 95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31129051 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30570958 |
| 97 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30425187 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30147573 |
| 99 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27348941 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26232079 |
| 101 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25882281 |
| 102 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25882281 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25743671 |
| 104 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.25308274 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24516612 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24470551 |
| 107 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23045017 |
| 108 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20395764 |
| 109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20362327 |
| 110 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19743824 |
| 111 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18777266 |
| 112 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18607206 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16862229 |
| 114 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15865655 |
| 115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15563586 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15484582 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12900952 |
| 118 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11849801 |
| 119 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.10373080 |
| 120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09277265 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08831578 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05984884 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05766532 |
| 124 | EWS_26573619_Chip-Seq_HEK293_Human | 1.05331826 |
| 125 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04766894 |
| 126 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04582615 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03027539 |
| 128 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02582596 |
| 129 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02503208 |
| 130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01990334 |
| 131 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01810625 |
| 132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00850235 |
| 133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99736985 |
| 134 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99601885 |
| 135 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98866378 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98577395 |
| 137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98030540 |
| 138 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96590855 |
| 139 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96510146 |
| 140 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95508805 |
| 141 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95186160 |
| 142 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92978652 |
| 143 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92707411 |
| 144 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89251082 |
| 145 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88292832 |
| 146 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87808275 |
| 147 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87539052 |
| 148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87081759 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87081759 |
| 150 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85920250 |
| 151 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84970784 |
| 152 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81303743 |
| 153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81186953 |
| 154 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80451807 |
| 155 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78687987 |
| 156 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78169294 |
| 157 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.76905165 |
| 158 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.75711119 |
| 159 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73597799 |
| 160 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.72786864 |
| 161 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72758413 |
| 162 | SA1_27219007_Chip-Seq_Bcells_Human | 0.70678280 |
| 163 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.70017319 |
| 164 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68880348 |
| 165 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.68053846 |
| 166 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.67398731 |
| 167 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.66377986 |
| 168 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.66377986 |
| 169 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.65697228 |
| 170 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.65625307 |
| 171 | NFYB_21822215_ChIP-Seq_K562_Human | 0.64874581 |
| 172 | CBP_21632823_ChIP-Seq_H3396_Human | 0.64676848 |
| 173 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64505486 |
| 174 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64482694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.95366534 |
| 2 | MP0000751_myopathy | 6.07953882 |
| 3 | MP0004036_abnormal_muscle_relaxation | 4.55449636 |
| 4 | MP0003136_yellow_coat_color | 4.30123120 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.98498209 |
| 6 | MP0001188_hyperpigmentation | 3.84160611 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.82769297 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.66975771 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.48968270 |
| 10 | MP0004381_abnormal_hair_follicle | 3.41125478 |
| 11 | MP0000566_synostosis | 3.38593055 |
| 12 | MP0000747_muscle_weakness | 3.31603909 |
| 13 | MP0000759_abnormal_skeletal_muscle | 3.26942920 |
| 14 | MP0005369_muscle_phenotype | 3.07650723 |
| 15 | MP0005330_cardiomyopathy | 3.03837434 |
| 16 | MP0004130_abnormal_muscle_cell | 3.00456107 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.98346947 |
| 18 | MP0002269_muscular_atrophy | 2.98178498 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.93626089 |
| 20 | MP0004233_abnormal_muscle_weight | 2.85173510 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.78877933 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 2.77373766 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.75915066 |
| 24 | MP0005409_darkened_coat_color | 2.73787526 |
| 25 | MP0005171_absent_coat_pigmentation | 2.65591298 |
| 26 | MP0004215_abnormal_myocardial_fiber | 2.51388432 |
| 27 | MP0002972_abnormal_cardiac_muscle | 2.49753450 |
| 28 | MP0003941_abnormal_skin_development | 2.41906487 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 2.38743907 |
| 30 | MP0002102_abnormal_ear_morphology | 2.33465603 |
| 31 | MP0003880_abnormal_central_pattern | 2.32994728 |
| 32 | MP0005423_abnormal_somatic_nervous | 2.29107375 |
| 33 | MP0004484_altered_response_of | 2.15808944 |
| 34 | MP0004742_abnormal_vestibular_system | 2.09600603 |
| 35 | MP0004510_myositis | 2.04704954 |
| 36 | MP0009379_abnormal_foot_pigmentation | 2.02828946 |
| 37 | MP0001486_abnormal_startle_reflex | 2.01631622 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.97718493 |
| 39 | MP0005379_endocrine/exocrine_gland_phen | 1.90834371 |
| 40 | MP0000733_abnormal_muscle_development | 1.87148323 |
| 41 | MP0004142_abnormal_muscle_tone | 1.81496846 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.81052833 |
| 43 | MP0002108_abnormal_muscle_morphology | 1.77634799 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.76501863 |
| 45 | MP0006138_congestive_heart_failure | 1.76105892 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.72750869 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.72750869 |
| 48 | MP0002127_abnormal_cardiovascular_syste | 1.66697414 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.61063774 |
| 50 | MP0003938_abnormal_ear_development | 1.56992464 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.56840375 |
| 52 | MP0000026_abnormal_inner_ear | 1.54822694 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.52801371 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.50378004 |
| 55 | MP0002638_abnormal_pupillary_reflex | 1.45487098 |
| 56 | MP0000383_abnormal_hair_follicle | 1.42776518 |
| 57 | MP0005266_abnormal_metabolism | 1.39831919 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.39558922 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.36917993 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 1.35732486 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.34555040 |
| 62 | MP0001905_abnormal_dopamine_level | 1.32747461 |
| 63 | MP0003787_abnormal_imprinting | 1.32346627 |
| 64 | MP0005451_abnormal_body_composition | 1.30093088 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.29096589 |
| 66 | MP0005670_abnormal_white_adipose | 1.28437703 |
| 67 | MP0001963_abnormal_hearing_physiology | 1.26820218 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.25946249 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.23650128 |
| 70 | MP0000762_abnormal_tongue_morphology | 1.22022032 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.19224408 |
| 72 | MP0005253_abnormal_eye_physiology | 1.17786459 |
| 73 | MP0000049_abnormal_middle_ear | 1.15967110 |
| 74 | MP0000920_abnormal_myelination | 1.15345758 |
| 75 | MP0003950_abnormal_plasma_membrane | 1.13984638 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 1.13648467 |
| 77 | MP0002272_abnormal_nervous_system | 1.11959879 |
| 78 | MP0003724_increased_susceptibility_to | 1.11484956 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 1.09717254 |
| 80 | MP0009745_abnormal_behavioral_response | 1.09173245 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.08354552 |
| 82 | MP0003718_maternal_effect | 1.08334977 |
| 83 | MP0008995_early_reproductive_senescence | 1.08190807 |
| 84 | MP0002971_abnormal_brown_adipose | 1.06922885 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 1.06767856 |
| 86 | MP0000613_abnormal_salivary_gland | 1.06556856 |
| 87 | MP0008260_abnormal_autophagy | 1.05622455 |
| 88 | MP0000778_abnormal_nervous_system | 1.05083871 |
| 89 | MP0002095_abnormal_skin_pigmentation | 1.02575577 |
| 90 | MP0002752_abnormal_somatic_nervous | 1.01750153 |
| 91 | MP0002163_abnormal_gland_morphology | 1.01154992 |
| 92 | MP0004085_abnormal_heartbeat | 1.01032349 |
| 93 | MP0000579_abnormal_nail_morphology | 1.00425720 |
| 94 | MP0001661_extended_life_span | 0.99578352 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.99065086 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.98405329 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.97265351 |
| 98 | MP0002938_white_spotting | 0.95797402 |
| 99 | MP0001968_abnormal_touch/_nociception | 0.95488709 |
| 100 | MP0002735_abnormal_chemical_nociception | 0.94500396 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.93367340 |
| 102 | MP0004270_analgesia | 0.93146132 |
| 103 | MP0008789_abnormal_olfactory_epithelium | 0.92667008 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.91715953 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.91655624 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.91550938 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.91292509 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.90952626 |
| 109 | MP0008058_abnormal_DNA_repair | 0.90088946 |
| 110 | MP0009046_muscle_twitch | 0.87598058 |
| 111 | MP0002572_abnormal_emotion/affect_behav | 0.86667381 |
| 112 | MP0003828_pulmonary_edema | 0.86356013 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.85781831 |
| 114 | MP0002177_abnormal_outer_ear | 0.83060840 |
| 115 | MP0002933_joint_inflammation | 0.83004883 |
| 116 | MP0000462_abnormal_digestive_system | 0.82800251 |
| 117 | MP0002132_abnormal_respiratory_system | 0.81484739 |
| 118 | MP0002751_abnormal_autonomic_nervous | 0.81240587 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.80760080 |
| 120 | MP0003878_abnormal_ear_physiology | 0.78527003 |
| 121 | MP0005377_hearing/vestibular/ear_phenot | 0.78527003 |
| 122 | MP0001727_abnormal_embryo_implantation | 0.77791760 |
| 123 | MP0002098_abnormal_vibrissa_morphology | 0.76130423 |
| 124 | MP0004147_increased_porphyrin_level | 0.76114878 |
| 125 | MP0002734_abnormal_mechanical_nocicepti | 0.74962824 |
| 126 | MP0004133_heterotaxia | 0.74943054 |
| 127 | MP0002184_abnormal_innervation | 0.74455542 |
| 128 | MP0009250_abnormal_appendicular_skeleto | 0.74067320 |
| 129 | MP0005671_abnormal_response_to | 0.73703682 |
| 130 | MP0001664_abnormal_digestion | 0.73432905 |
| 131 | MP0002822_catalepsy | 0.73322048 |
| 132 | MP0003195_calcinosis | 0.72445869 |
| 133 | MP0001440_abnormal_grooming_behavior | 0.72384467 |
| 134 | MP0005410_abnormal_fertilization | 0.72082377 |
| 135 | MP0000470_abnormal_stomach_morphology | 0.71811154 |
| 136 | MP0000266_abnormal_heart_morphology | 0.71366361 |
| 137 | MP0000749_muscle_degeneration | 0.71023957 |
| 138 | MP0009780_abnormal_chondrocyte_physiolo | 0.71017493 |
| 139 | MP0001529_abnormal_vocalization | 0.70410938 |
| 140 | MP0001984_abnormal_olfaction | 0.68380558 |
| 141 | MP0003786_premature_aging | 0.67400608 |
| 142 | MP0009785_altered_susceptibility_to | 0.67208412 |
| 143 | MP0002736_abnormal_nociception_after | 0.66849571 |
| 144 | MP0004134_abnormal_chest_morphology | 0.66847670 |
| 145 | MP0003045_fibrosis | 0.64579084 |
| 146 | MP0005394_taste/olfaction_phenotype | 0.63723546 |
| 147 | MP0005165_increased_susceptibility_to | 0.62200511 |
| 148 | MP0003656_abnormal_erythrocyte_physiolo | 0.58127468 |
| 149 | MP0004043_abnormal_pH_regulation | 0.50632899 |
| 150 | MP0002078_abnormal_glucose_homeostasis | 0.50443298 |
| 151 | MP0008569_lethality_at_weaning | 0.49812750 |
| 152 | MP0003879_abnormal_hair_cell | 0.48915786 |
| 153 | MP0001299_abnormal_eye_distance/ | 0.48692933 |
| 154 | MP0002128_abnormal_blood_circulation | 0.45446259 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37807890 |
| 156 | MP0010030_abnormal_orbit_morphology | 0.37336078 |
| 157 | MP0005535_abnormal_body_temperature | 0.37266710 |
| 158 | MP0005376_homeostasis/metabolism_phenot | 0.37084474 |
| 159 | MP0006035_abnormal_mitochondrial_morpho | 0.36658984 |
| 160 | MP0000230_abnormal_systemic_arterial | 0.35045139 |
| 161 | MP0005167_abnormal_blood-brain_barrier | 0.34748157 |
| 162 | MP0005334_abnormal_fat_pad | 0.32398046 |
| 163 | MP0005452_abnormal_adipose_tissue | 0.31924227 |
| 164 | MP0005332_abnormal_amino_acid | 0.31738433 |
| 165 | MP0009672_abnormal_birth_weight | 0.31246355 |
| 166 | MP0005166_decreased_susceptibility_to | 0.28124356 |
| 167 | MP0003948_abnormal_gas_homeostasis | 0.27568536 |
| 168 | MP0005187_abnormal_penis_morphology | 0.27167120 |
| 169 | MP0005083_abnormal_biliary_tract | 0.26668987 |
| 170 | MP0005319_abnormal_enzyme/_coenzyme | 0.24927105 |
| 171 | MP0004924_abnormal_behavior | 0.24849431 |
| 172 | MP0005386_behavior/neurological_phenoty | 0.24849431 |
| 173 | MP0002114_abnormal_axial_skeleton | 0.24323021 |
| 174 | MP0000343_altered_response_to | 0.22489006 |
| 175 | MP0001346_abnormal_lacrimal_gland | 0.22402199 |
| 176 | MP0002066_abnormal_motor_capabilities/c | 0.22018702 |
| 177 | MP0002896_abnormal_bone_mineralization | 0.21876162 |
| 178 | MP0001943_abnormal_respiration | 0.17531875 |
| 179 | MP0009115_abnormal_fat_cell | 0.17164160 |
| 180 | MP0008874_decreased_physiological_sensi | 0.15925419 |
| 181 | MP0002234_abnormal_pharynx_morphology | 0.13420027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 8.05495127 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.91222814 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.61272977 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.90302934 |
| 5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.70638206 |
| 6 | EMG: myopathic abnormalities (HP:0003458) | 5.57169857 |
| 7 | Distal arthrogryposis (HP:0005684) | 5.39412188 |
| 8 | Myopathic facies (HP:0002058) | 5.39354519 |
| 9 | Duplicated collecting system (HP:0000081) | 5.33925722 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.17639072 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.14965847 |
| 12 | Rhabdomyolysis (HP:0003201) | 4.99039728 |
| 13 | Myoglobinuria (HP:0002913) | 4.97428678 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 4.96455045 |
| 15 | Chromsome breakage (HP:0040012) | 4.87235105 |
| 16 | Abnormality of the renal collecting system (HP:0004742) | 4.75841642 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.65271287 |
| 18 | Neck muscle weakness (HP:0000467) | 4.54434577 |
| 19 | Rimmed vacuoles (HP:0003805) | 4.49565273 |
| 20 | Subaortic stenosis (HP:0001682) | 4.47391042 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.47391042 |
| 22 | Round ear (HP:0100830) | 4.41883323 |
| 23 | Sudden death (HP:0001699) | 4.37888082 |
| 24 | Ulnar deviation of the wrist (HP:0003049) | 4.15445543 |
| 25 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.14336798 |
| 26 | Bundle branch block (HP:0011710) | 4.06548194 |
| 27 | Difficulty running (HP:0009046) | 3.97119757 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 3.91835433 |
| 29 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.91835433 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 3.88301516 |
| 31 | Increased connective tissue (HP:0009025) | 3.71775028 |
| 32 | Calcaneovalgus deformity (HP:0001848) | 3.65105786 |
| 33 | Abnormal ciliary motility (HP:0012262) | 3.61325054 |
| 34 | Upper limb muscle weakness (HP:0003484) | 3.59997570 |
| 35 | Muscle stiffness (HP:0003552) | 3.57689610 |
| 36 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.52910503 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 3.47377487 |
| 38 | Areflexia of lower limbs (HP:0002522) | 3.44834485 |
| 39 | Frequent falls (HP:0002359) | 3.40651156 |
| 40 | Absent phalangeal crease (HP:0006109) | 3.34450380 |
| 41 | EMG: neuropathic changes (HP:0003445) | 3.28871960 |
| 42 | Myotonia (HP:0002486) | 3.26479421 |
| 43 | Deformed tarsal bones (HP:0008119) | 3.22890021 |
| 44 | Ventricular tachycardia (HP:0004756) | 3.20933391 |
| 45 | Congenital sensorineural hearing impairment (HP:0008527) | 3.10603240 |
| 46 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.09833154 |
| 47 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.09833154 |
| 48 | Parakeratosis (HP:0001036) | 3.02263152 |
| 49 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.00633097 |
| 50 | Dilated cardiomyopathy (HP:0001644) | 3.00590136 |
| 51 | Generalized muscle weakness (HP:0003324) | 2.92013714 |
| 52 | Duplication of thumb phalanx (HP:0009942) | 2.88226506 |
| 53 | Reticulocytopenia (HP:0001896) | 2.85466933 |
| 54 | Abnormality of DNA repair (HP:0003254) | 2.83402325 |
| 55 | Lipoatrophy (HP:0100578) | 2.81867866 |
| 56 | Septo-optic dysplasia (HP:0100842) | 2.77546838 |
| 57 | Abnormal finger flexion creases (HP:0006143) | 2.76440914 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.73110267 |
| 59 | Malignant hyperthermia (HP:0002047) | 2.71513825 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.70160581 |
| 61 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.69608594 |
| 62 | Abnormality of the preputium (HP:0100587) | 2.65624730 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.58745949 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 2.58322477 |
| 65 | Decreased central vision (HP:0007663) | 2.56744653 |
| 66 | Heart block (HP:0012722) | 2.55795880 |
| 67 | Conical tooth (HP:0000698) | 2.55423142 |
| 68 | Stomach cancer (HP:0012126) | 2.48100420 |
| 69 | Bulbar palsy (HP:0001283) | 2.43615101 |
| 70 | Progressive muscle weakness (HP:0003323) | 2.42883818 |
| 71 | Scapular winging (HP:0003691) | 2.41364838 |
| 72 | Patchy hypopigmentation of hair (HP:0011365) | 2.40548665 |
| 73 | Abnormal atrioventricular conduction (HP:0005150) | 2.39687985 |
| 74 | Renal Fanconi syndrome (HP:0001994) | 2.37342235 |
| 75 | Limb-girdle muscle atrophy (HP:0003797) | 2.37273909 |
| 76 | Abnormality of the septum pellucidum (HP:0007375) | 2.36119724 |
| 77 | Clubbing of toes (HP:0100760) | 2.36025801 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.35688479 |
| 79 | Gowers sign (HP:0003391) | 2.31030517 |
| 80 | Absent septum pellucidum (HP:0001331) | 2.30919813 |
| 81 | Slender build (HP:0001533) | 2.28579295 |
| 82 | Osteomalacia (HP:0002749) | 2.28478752 |
| 83 | White forelock (HP:0002211) | 2.27942525 |
| 84 | Atelectasis (HP:0100750) | 2.27875625 |
| 85 | Abnormality of the axillary hair (HP:0100134) | 2.27670683 |
| 86 | Abnormality of secondary sexual hair (HP:0009888) | 2.27670683 |
| 87 | Weak cry (HP:0001612) | 2.27642281 |
| 88 | Abnormality of the foot musculature (HP:0001436) | 2.27504521 |
| 89 | Abnormality of incisor morphology (HP:0011063) | 2.27027561 |
| 90 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.26355621 |
| 91 | Submucous cleft hard palate (HP:0000176) | 2.25170816 |
| 92 | Aplasia cutis congenita (HP:0001057) | 2.24751432 |
| 93 | Ventricular arrhythmia (HP:0004308) | 2.24489075 |
| 94 | Meckel diverticulum (HP:0002245) | 2.21336425 |
| 95 | Ragged-red muscle fibers (HP:0003200) | 2.20169165 |
| 96 | Attenuation of retinal blood vessels (HP:0007843) | 2.19109928 |
| 97 | Optic nerve hypoplasia (HP:0000609) | 2.18083696 |
| 98 | Prostate neoplasm (HP:0100787) | 2.16582491 |
| 99 | Muscular dystrophy (HP:0003560) | 2.15985312 |
| 100 | Proximal amyotrophy (HP:0007126) | 2.12796846 |
| 101 | Difficulty climbing stairs (HP:0003551) | 2.12343138 |
| 102 | Abnormality of the ileum (HP:0001549) | 2.10655862 |
| 103 | Increased hepatocellular lipid droplets (HP:0006565) | 2.10173555 |
| 104 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.09705119 |
| 105 | Spinal rigidity (HP:0003306) | 2.09463391 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 2.05813088 |
| 107 | Abnormality of the calcaneus (HP:0008364) | 2.03993507 |
| 108 | Fatigable weakness (HP:0003473) | 2.02578636 |
| 109 | Abnormality of the neuromuscular junction (HP:0003398) | 2.02578636 |
| 110 | Increased corneal curvature (HP:0100692) | 2.01675495 |
| 111 | Keratoconus (HP:0000563) | 2.01675495 |
| 112 | Ectopic kidney (HP:0000086) | 2.01437200 |
| 113 | Hip contracture (HP:0003273) | 2.01235230 |
| 114 | Waddling gait (HP:0002515) | 2.00136932 |
| 115 | Muscle fiber inclusion bodies (HP:0100299) | 10.7562963 |
| 116 | Nemaline bodies (HP:0003798) | 10.6247724 |
| 117 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.3464974 |
| 118 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99459069 |
| 119 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.98955709 |
| 120 | Obstructive lung disease (HP:0006536) | 1.98053001 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98053001 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.97815310 |
| 123 | Exercise intolerance (HP:0003546) | 1.97620883 |
| 124 | Febrile seizures (HP:0002373) | 1.97464336 |
| 125 | Nonprogressive disorder (HP:0003680) | 1.97141296 |
| 126 | Pulmonary artery stenosis (HP:0004415) | 1.96271572 |
| 127 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.93863977 |
| 128 | Atrial fibrillation (HP:0005110) | 1.93565232 |
| 129 | Hypoplasia of the fovea (HP:0007750) | 1.91829982 |
| 130 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.91829982 |
| 131 | Embryonal renal neoplasm (HP:0011794) | 1.91740568 |
| 132 | Ureteral duplication (HP:0000073) | 1.90451870 |
| 133 | Anomalous pulmonary venous return (HP:0010772) | 1.89501655 |
| 134 | Abnormality of renal resorption (HP:0011038) | 1.83945320 |
| 135 | Male pseudohermaphroditism (HP:0000037) | 1.83381259 |
| 136 | Distal lower limb muscle weakness (HP:0009053) | 1.82043992 |
| 137 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.81387564 |
| 138 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.81387564 |
| 139 | Progressive external ophthalmoplegia (HP:0000590) | 1.80436246 |
| 140 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.79869559 |
| 141 | Increased intramyocellular lipid droplets (HP:0012240) | 1.79417275 |
| 142 | Abnormal sex determination (HP:0012244) | 1.77777265 |
| 143 | Sex reversal (HP:0012245) | 1.77777265 |
| 144 | Primary atrial arrhythmia (HP:0001692) | 1.75679043 |
| 145 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75339934 |
| 146 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.74345218 |
| 147 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74205512 |
| 148 | Renal cortical cysts (HP:0000803) | 1.74086173 |
| 149 | Concave nail (HP:0001598) | 1.73941239 |
| 150 | Median cleft lip (HP:0000161) | 1.73666235 |
| 151 | Overfolded helix (HP:0000396) | 1.73148332 |
| 152 | Nasolacrimal duct obstruction (HP:0000579) | 1.72995636 |
| 153 | Tubulointerstitial nephritis (HP:0001970) | 1.72898657 |
| 154 | Hypergonadotropic hypogonadism (HP:0000815) | 1.72811216 |
| 155 | Renal agenesis (HP:0000104) | 1.72528039 |
| 156 | Shoulder girdle muscle weakness (HP:0003547) | 1.72295039 |
| 157 | Pelvic girdle muscle weakness (HP:0003749) | 1.71586478 |
| 158 | Limb-girdle muscle weakness (HP:0003325) | 1.71558690 |
| 159 | Syncope (HP:0001279) | 1.71279426 |
| 160 | Triphalangeal thumb (HP:0001199) | 1.71081676 |
| 161 | Xerostomia (HP:0000217) | 1.70488928 |
| 162 | Ventricular fibrillation (HP:0001663) | 1.70390875 |
| 163 | Supraventricular tachycardia (HP:0004755) | 1.69978775 |
| 164 | Abnormality of chromosome stability (HP:0003220) | 1.68080829 |
| 165 | Nephronophthisis (HP:0000090) | 1.67528990 |
| 166 | True hermaphroditism (HP:0010459) | 1.67443660 |
| 167 | Atrioventricular block (HP:0001678) | 1.66957527 |
| 168 | Increased muscle lipid content (HP:0009058) | 1.66310468 |
| 169 | Facial diplegia (HP:0001349) | 1.65125913 |
| 170 | Supraventricular arrhythmia (HP:0005115) | 1.64511879 |
| 171 | Palpitations (HP:0001962) | 1.64286329 |
| 172 | Partial duplication of thumb phalanx (HP:0009944) | 1.63639394 |
| 173 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.63148227 |
| 174 | Microvesicular hepatic steatosis (HP:0001414) | 1.62708217 |
| 175 | Fetal akinesia sequence (HP:0001989) | 1.61896619 |
| 176 | Abnormality of molar (HP:0011077) | 1.61865841 |
| 177 | Abnormality of molar morphology (HP:0011070) | 1.61865841 |
| 178 | Hypothermia (HP:0002045) | 1.61231014 |
| 179 | Fair hair (HP:0002286) | 1.60965066 |
| 180 | Recurrent pneumonia (HP:0006532) | 1.60275727 |
| 181 | Abnormality of the pulmonary veins (HP:0011718) | 1.60236637 |
| 182 | Hyperkalemia (HP:0002153) | 1.59678598 |
| 183 | Optic disc pallor (HP:0000543) | 1.58558292 |
| 184 | Retrobulbar optic neuritis (HP:0100654) | 1.57555788 |
| 185 | Optic neuritis (HP:0100653) | 1.57555788 |
| 186 | Abnormality of the renal medulla (HP:0100957) | 1.56642085 |
| 187 | Medial flaring of the eyebrow (HP:0010747) | 1.56456718 |
| 188 | Paralysis (HP:0003470) | 1.55277526 |
| 189 | Oligomenorrhea (HP:0000876) | 1.53478026 |
| 190 | Steppage gait (HP:0003376) | 1.53222148 |
| 191 | Left ventricular hypertrophy (HP:0001712) | 1.53123619 |
| 192 | Long clavicles (HP:0000890) | 1.49641984 |
| 193 | Metatarsus adductus (HP:0001840) | 1.41175126 |
| 194 | Ulnar deviation of finger (HP:0009465) | 1.39258638 |
| 195 | Right ventricular cardiomyopathy (HP:0011663) | 1.37092851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.50443806 |
| 2 | CASK | 3.76202154 |
| 3 | STK16 | 3.70373778 |
| 4 | IRAK3 | 3.49326092 |
| 5 | ZAK | 3.15048031 |
| 6 | TNIK | 3.00822920 |
| 7 | IRAK4 | 2.76197413 |
| 8 | IRAK2 | 2.06271329 |
| 9 | BLK | 2.03785218 |
| 10 | MKNK2 | 1.94808796 |
| 11 | PKN1 | 1.93305098 |
| 12 | MAPK12 | 1.91093999 |
| 13 | BMPR1B | 1.82474281 |
| 14 | TXK | 1.78336957 |
| 15 | GRK1 | 1.73347097 |
| 16 | STK39 | 1.69319905 |
| 17 | ADRBK2 | 1.66939406 |
| 18 | EIF2AK2 | 1.66482828 |
| 19 | GRK7 | 1.65072481 |
| 20 | MAP3K7 | 1.63921050 |
| 21 | MARK1 | 1.63828978 |
| 22 | NEK6 | 1.63114438 |
| 23 | MAP2K3 | 1.61240191 |
| 24 | IRAK1 | 1.58846848 |
| 25 | MUSK | 1.58648236 |
| 26 | DMPK | 1.55287519 |
| 27 | NUAK1 | 1.50188665 |
| 28 | INSRR | 1.42740932 |
| 29 | PLK4 | 1.35897669 |
| 30 | PRPF4B | 1.33871155 |
| 31 | NME1 | 1.31040108 |
| 32 | TLK1 | 1.28360483 |
| 33 | TRPM7 | 1.26398975 |
| 34 | MAPKAPK3 | 1.26239962 |
| 35 | OBSCN | 1.26016007 |
| 36 | PBK | 1.25016470 |
| 37 | YES1 | 1.22869206 |
| 38 | MAP3K14 | 1.21615741 |
| 39 | MKNK1 | 1.21139396 |
| 40 | OXSR1 | 1.18270377 |
| 41 | NEK1 | 1.15226148 |
| 42 | LIMK1 | 1.14258052 |
| 43 | SRPK1 | 1.13158394 |
| 44 | CLK1 | 1.11776899 |
| 45 | PHKG1 | 1.08965728 |
| 46 | PHKG2 | 1.08965728 |
| 47 | BMPR2 | 1.08514334 |
| 48 | MAP2K7 | 1.06495685 |
| 49 | MAP2K4 | 1.04927457 |
| 50 | PIK3CG | 1.04003611 |
| 51 | MAPK13 | 1.03448786 |
| 52 | PDK2 | 0.99348653 |
| 53 | TNK2 | 0.96428120 |
| 54 | PRKAA2 | 0.94093033 |
| 55 | DYRK2 | 0.93860214 |
| 56 | PINK1 | 0.89074089 |
| 57 | EPHA2 | 0.88228224 |
| 58 | EEF2K | 0.86824339 |
| 59 | CDK3 | 0.86627311 |
| 60 | MAPK15 | 0.85378318 |
| 61 | MYLK | 0.83797552 |
| 62 | TEC | 0.81505230 |
| 63 | PRKAA1 | 0.80714443 |
| 64 | MOS | 0.77253361 |
| 65 | NTRK3 | 0.77167693 |
| 66 | MAP2K6 | 0.76680240 |
| 67 | CCNB1 | 0.76115162 |
| 68 | NEK9 | 0.75085407 |
| 69 | CSNK1A1L | 0.73711040 |
| 70 | PRKCE | 0.72542822 |
| 71 | IKBKE | 0.72443902 |
| 72 | ERBB3 | 0.72369051 |
| 73 | RPS6KA5 | 0.71821559 |
| 74 | FES | 0.69842859 |
| 75 | CAMK4 | 0.68335100 |
| 76 | BCKDK | 0.66874787 |
| 77 | TTK | 0.65396873 |
| 78 | VRK1 | 0.64920100 |
| 79 | PRKCQ | 0.64273611 |
| 80 | DYRK3 | 0.63840952 |
| 81 | DYRK1B | 0.62946352 |
| 82 | FGR | 0.62873296 |
| 83 | WNK1 | 0.62483627 |
| 84 | CAMK2B | 0.62324994 |
| 85 | WNK4 | 0.62081638 |
| 86 | BCR | 0.62028555 |
| 87 | IKBKB | 0.60980109 |
| 88 | BRD4 | 0.59535972 |
| 89 | BRAF | 0.58861736 |
| 90 | TIE1 | 0.58860268 |
| 91 | AKT2 | 0.57933586 |
| 92 | PIK3CA | 0.55336689 |
| 93 | CAMK2D | 0.55105466 |
| 94 | MAP3K13 | 0.55022622 |
| 95 | PRKG1 | 0.53604573 |
| 96 | NLK | 0.52257676 |
| 97 | PRKD2 | 0.51508265 |
| 98 | RIPK1 | 0.50888351 |
| 99 | CSNK1G3 | 0.50335095 |
| 100 | MAPK4 | 0.50113783 |
| 101 | ROCK1 | 0.50014046 |
| 102 | LYN | 0.49720477 |
| 103 | CAMK2A | 0.49586467 |
| 104 | CDC42BPA | 0.48766492 |
| 105 | MAP2K1 | 0.47919920 |
| 106 | DYRK1A | 0.47649715 |
| 107 | CAMK2G | 0.47546000 |
| 108 | STK38L | 0.47457998 |
| 109 | UHMK1 | 0.46879106 |
| 110 | MAPK7 | 0.46707485 |
| 111 | CSNK1G1 | 0.46068450 |
| 112 | KSR2 | 0.43209059 |
| 113 | SGK3 | 0.43009604 |
| 114 | MAPK11 | 0.42019846 |
| 115 | SGK494 | 0.40149467 |
| 116 | SGK223 | 0.40149467 |
| 117 | PRKACA | 0.39203709 |
| 118 | LATS2 | 0.39184894 |
| 119 | SIK2 | 0.37266824 |
| 120 | MAPKAPK5 | 0.37076879 |
| 121 | AKT3 | 0.36592406 |
| 122 | HCK | 0.36571839 |
| 123 | NTRK2 | 0.35411223 |
| 124 | SGK1 | 0.34950594 |
| 125 | TRIB3 | 0.34576907 |
| 126 | EPHA4 | 0.33417101 |
| 127 | ROCK2 | 0.33224594 |
| 128 | LCK | 0.33101013 |
| 129 | PRKD1 | 0.32505694 |
| 130 | EPHA3 | 0.32247511 |
| 131 | SGK2 | 0.30637975 |
| 132 | CAMK1 | 0.30196354 |
| 133 | PRKCI | 0.29901654 |
| 134 | PAK3 | 0.29239290 |
| 135 | CSNK1A1 | 0.28689616 |
| 136 | CSK | 0.28401475 |
| 137 | BTK | 0.28222204 |
| 138 | RPS6KA3 | 0.28033876 |
| 139 | TBK1 | 0.26441680 |
| 140 | RPS6KA1 | 0.26375344 |
| 141 | RPS6KL1 | 0.26189070 |
| 142 | RPS6KC1 | 0.26189070 |
| 143 | PRKACB | 0.24768336 |
| 144 | ICK | 0.23146439 |
| 145 | MAPK10 | 0.22432673 |
| 146 | PRKACG | 0.22407870 |
| 147 | MAP3K1 | 0.22242044 |
| 148 | RPS6KA6 | 0.22133390 |
| 149 | RPS6KB1 | 0.21411918 |
| 150 | ARAF | 0.19831950 |
| 151 | PDPK1 | 0.19187494 |
| 152 | TAOK2 | 0.18159522 |
| 153 | EPHB1 | 0.17636229 |
| 154 | MAP3K6 | 0.16736098 |
| 155 | ZAP70 | 0.14490885 |
| 156 | MARK3 | 0.13915809 |
| 157 | PDK1 | 0.13573072 |
| 158 | RPS6KB2 | 0.12860828 |
| 159 | STK11 | 0.11752204 |
| 160 | MTOR | 0.11003287 |
| 161 | TGFBR2 | 0.10457901 |
| 162 | DAPK2 | 0.10369753 |
| 163 | SIK1 | 0.08727631 |
| 164 | MAP3K5 | 0.08419624 |
| 165 | MARK2 | 0.07927921 |
| 166 | RAF1 | 0.07663713 |
| 167 | STK24 | 0.07038938 |
| 168 | MAP3K11 | 0.04656442 |
| 169 | MAP3K3 | 0.04191954 |
| 170 | KSR1 | 0.03815412 |
| 171 | MAPK9 | 0.03465767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.37616335 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.12598703 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.77626140 |
| 4 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.89638903 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.81734087 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.50553700 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.46051619 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.26655989 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.24164865 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.24152414 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.08295654 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.08009003 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 1.96176935 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93094142 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 1.92785483 |
| 16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.88985448 |
| 17 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.84817061 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84668559 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.82832460 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.79315543 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74362380 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.73006514 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70550231 |
| 24 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.68709602 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.65340356 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.65338615 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65168054 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64082224 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63636763 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62019847 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.58448049 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.55968513 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.55765079 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.53729545 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.53561090 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.52205076 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49769529 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48240825 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47559606 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.47213061 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45448579 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44266211 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42645277 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42186705 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.40696464 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40529427 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36186961 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.35003387 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34802247 |
| 50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.34403968 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33876789 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30393800 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30170154 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.29577228 |
| 55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27378477 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24813605 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.21549097 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20765946 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.19920635 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17392732 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16490189 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15985097 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13971250 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13614945 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 1.12531517 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11418445 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09236800 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 1.08142495 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08108704 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.03060597 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01222635 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00416005 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96620421 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.96369808 |
| 75 | Axon guidance_Homo sapiens_hsa04360 | 0.96312679 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94717325 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93672180 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.91730099 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90961128 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.89540602 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88563186 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86620271 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85036351 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83657455 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82074966 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80120046 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79251459 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79161721 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78480389 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77635282 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.73232968 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73222721 |
| 93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71150388 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.71083071 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.70762272 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70049274 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68628141 |
| 98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67711635 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.67606842 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67356210 |
| 101 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65391842 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64384535 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63945675 |
| 104 | Proteasome_Homo sapiens_hsa03050 | 0.63810249 |
| 105 | Mismatch repair_Homo sapiens_hsa03430 | 0.63025503 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62450195 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62217649 |
| 108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60761153 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.58589489 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57532197 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.57116238 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57114681 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56371400 |
| 114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55260946 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54611494 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53104477 |
| 117 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50613402 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49091221 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47977037 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47647231 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46906539 |
| 122 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46521118 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.46123439 |
| 124 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45930998 |
| 125 | Focal adhesion_Homo sapiens_hsa04510 | 0.45668639 |
| 126 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.45034995 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44913731 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44231399 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43739852 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42912411 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42701794 |
| 132 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42475482 |
| 133 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41237463 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40672848 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39582847 |
| 136 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.38592586 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38378120 |
| 138 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38315798 |
| 139 | RNA degradation_Homo sapiens_hsa03018 | 0.38026424 |
| 140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37147854 |
| 141 | Salivary secretion_Homo sapiens_hsa04970 | 0.36874544 |
| 142 | Peroxisome_Homo sapiens_hsa04146 | 0.36515863 |
| 143 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36182017 |
| 144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35924179 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34543130 |
| 146 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34197505 |
| 147 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32737298 |
| 148 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.32660108 |
| 149 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32656393 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32622254 |
| 151 | Long-term depression_Homo sapiens_hsa04730 | 0.32193726 |
| 152 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31132760 |
| 153 | Lysine degradation_Homo sapiens_hsa00310 | 0.30851671 |
| 154 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30808410 |
| 155 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30562769 |
| 156 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30409753 |
| 157 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29817289 |
| 158 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29255963 |
| 159 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27464503 |
| 160 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27065188 |
| 161 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26920722 |
| 162 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19914321 |
| 163 | Adherens junction_Homo sapiens_hsa04520 | 0.17573123 |
| 164 | Platelet activation_Homo sapiens_hsa04611 | 0.16983008 |
| 165 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16759397 |
| 166 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15691239 |
| 167 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15417635 |
| 168 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.13706649 |
| 169 | Bile secretion_Homo sapiens_hsa04976 | 0.11268497 |
| 170 | Melanogenesis_Homo sapiens_hsa04916 | 0.11056422 |
| 171 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09922753 |
| 172 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08758142 |
| 173 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.08510201 |
| 174 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.07341577 |
| 175 | Gap junction_Homo sapiens_hsa04540 | 0.06876809 |
| 176 | Amoebiasis_Homo sapiens_hsa05146 | 0.06521897 |

